- Home
- PCT vs CNTA Comparison
PCT vs CNTA Comparison
Compare PCT & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PCT | CNTA |
|---|---|---|
| Founded | 2015 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Environmental Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 3.7B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | PCT | CNTA |
|---|---|---|
| Price | $8.70 | $24.76 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | $13.67 | ★ $37.70 |
| AVG Volume (30 Days) | ★ 3.5M | 1.3M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $5,660,000.00 | ★ $15,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $707.73 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 118.88 |
| 52 Week Low | $5.40 | $9.60 |
| 52 Week High | $17.37 | $30.58 |
Technical Indicators
Market Signals| Indicator | PCT | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 45.22 | 39.46 |
| Support Level | $8.91 | $24.17 |
| Resistance Level | $9.45 | $26.01 |
| Average True Range (ATR) | 0.58 | 1.19 |
| MACD | 0.13 | -0.35 |
| Stochastic Oscillator | 53.51 | 10.51 |
Price Performance
Historical ComparisonAbout PCT PureCycle Technologies Inc.
PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.